Company intelligence / Profile preview

ValenTx

Maple Grove, Minnesota, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~6
Development stage: Clinical

Overview

ValenTx has developed a non-surgical, implantable medical device therapy for morbid obesity and type 2 diabetes. The company reports "unsurpassed efficacy data" from a series of human clinical trials and is expanding operations to broaden the therapy's utility. Specific trial results are not publicly detailed.

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Device (implantable medical device)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on ValenTx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ValenTx.

Explore the full profile